Sernova Corp.(SEOVF.US)

Last Updated 19:00:00 ET
longbridge loading

Keenova Reports First Quarter 2026 Financial Results | MNK Stock News

StockTitan·
US
SEOVF
-6.34%
US
ITRM
0.00%
US
NBRVF
0.00%
StockTitan·
US
SEOVF
-6.34%
US
ITRM
0.00%
US
NBRVF
0.00%

Keenova Launches New Consumer Campaign for Dupuytren's Contracture: Don't Be a Viking | MNK Stock News

StockTitan·
US
NBRVF
0.00%
US
ITRM
0.00%
US
SEOVF
-6.34%
StockTitan·
US
NBRVF
0.00%
US
ITRM
0.00%
US
SEOVF
-6.34%

Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at Digestive Disease Week | MNK Stock News

StockTitan·
US
ITRM
0.00%
US
NBRVF
0.00%
US
SEOVF
-6.34%
StockTitan·
US
ITRM
0.00%
US
NBRVF
0.00%
US
SEOVF
-6.34%

Sernova Biotherapeutics Announces Affirmative Voting Results from 2026 Annual General Meeting of Shareholders | SEOVF Stock News

StockTitan·
US
IXJ
+0.19%
US
VHT
-0.11%
US
IBBQ
+1.65%
StockTitan·
US
IXJ
+0.19%
US
VHT
-0.11%
US
IBBQ
+1.65%

06:30 ETKeenova Announces Unaudited Fourth Quarter 2025 Financial Results

prnewswire·
US
LABU
+10.56%
US
BBH
+0.52%
US
NBRVF
0.00%
prnewswire·
US
LABU
+10.56%
US
BBH
+0.52%
US
NBRVF
0.00%

Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at the SHM Converge | MNK Stock News

StockTitan·
US
RNVA
0.00%
US
SEOVF
-6.34%
StockTitan·
US
RNVA
0.00%
US
SEOVF
-6.34%
© 2026 Longbridge｜Disclaimer